Alphabet Inc.
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$4.02B
Q ending 2026-03-31
Prior quarter
$2.58B
Q ending 2025-12-31
Change
+55.7% QoQ · +154.6% YoY
Positions
26
reported holdings
Largest positions
All 26 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Cme Group Inc | CME | Shares | $1.03B | 3.5M |
| Planet Labs Pbc | PL | Shares | $985.2M | 35.2M |
| Ast Spacemobile Inc | ASTS | Shares | $741.1M | 8.9M |
| Revolution Medicines Inc | RVMD | Shares | $320.2M | 3.3M |
| Arm Holdings Plc | ARM | Shares | $296.6M | 2.0M |
| Freshworks Inc | FRSH | Shares | $130.1M | 16.2M |
| Uipath Inc | PATH | Shares | $78.1M | 7.0M |
| Tempus Ai Inc | TEM | Shares | $70.1M | 1.6M |
| Paypay Corp | PAYP | Shares | $66.7M | 3.1M |
| Gitlab Inc | GTLB | Shares | $59.0M | 2.7M |
| Prime Medicine Inc | PRME | Shares | $57.6M | 16.6M |
| Ethos Technologies Inc | LIFE | Shares | $42.1M | 3.8M |
| Maze Therapeutics Inc | MAZE | Shares | $41.4M | 1.4M |
| Bridgebio Oncology Therapeut | BBOT | Shares | $25.3M | 2.8M |
| Relay Therapeutics Inc | RLAY | Shares | $15.6M | 1.6M |
| Monte Rosa Therapeutics Inc | GLUE | Shares | $11.3M | 684K |
| Vera Therapeutics Inc | VERA | Shares | $9.7M | 241K |
| Sana Biotechnology Inc | SANA | Shares | $8.1M | 2.8M |
| Beam Therapeutics Inc | BEAM | Shares | $7.7M | 322K |
| Lyell Immunopharma Inc | LYEL | Shares | $5.9M | 293K |
| Oscar Health Inc | OSCR | Shares | $5.5M | 482K |
| Figma Inc | FIG | Shares | $4.6M | 216K |
| Spero Therapeutics Inc | SPRO | Shares | $2.1M | 890K |
| Hyperfine Inc | HYPR | Shares | $971K | 899K |
| Autolus Therapeutics Plc | AUTL | Shares | $964K | 698K |
| Tenaya Therapeutics Inc | TNYA | Shares | $632K | 916K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.